1.Significant gastrointestinal morbidity after sacrocolpopexy: The incidence and risk factors.
Yu Ri JO ; Ji Young KIM ; Myung Jae JEON
Obstetrics & Gynecology Science 2014;57(4):304-309
OBJECTIVE: This study aimed to quantify the risk of significant gastrointestinal (GI) morbidity after sacrocolpopexy (SCP), and to identify related risk factors. METHODS: A retrospective study was performed of 258 patients who underwent laparotomic SCP for symptomatic pelvic organ prolapse (POP) from November 2008 to August 2013. By the review of medical records, the frequency of significant GI morbidity that resulted in a prolonged initial hospitalization, readmission, or reoperation was assessed. Thereafter, risk factors for significant GI morbidity were assessed using univariate and multivariate analyses. RESULTS: Ten patients (3.9%) were identified as having significant GI morbidity; nine (3.5%) had a prolonged initial hospital stay or were readmitted for the medical treatment of postoperative ileus and 1 (0.4%) underwent reoperation for small bowel obstruction. The occurrence of significant GI morbidity was significantly associated with patient's age and prior laparotomy. By multivariable logistic regression analysis, age (odds ratio [OR], 1.14; 95% confidence interval [CI], 1.01-1.27; P=0.03) and prior laparotomy (OR, 6.82; 95% CI, 1.37-34.07; P=0.02) were found as independent risk factors for significant GI morbidity. CONCLUSION: One in 25 (3.9%) women after SCP experiences significant GI morbidity. Particularly, women with older age and prior laparotomy have a higher risk for significant GI morbidity. This data will aid preoperative counseling for Korean POP patients undergoing SCP.
Counseling
;
Female
;
Hospitalization
;
Humans
;
Ileus
;
Incidence*
;
Laparotomy
;
Length of Stay
;
Logistic Models
;
Medical Records
;
Multivariate Analysis
;
Pelvic Organ Prolapse
;
Reoperation
;
Retrospective Studies
;
Risk Factors*
2.Febrile Seizure Associated With COVID-19 in a Child: Case Report and Literature Review
Yu Ri JO ; Nayoung JUNG ; Min Kyoung KIM ; Young Se KWON ; Dong Hyun KIM
Pediatric Infection & Vaccine 2024;31(1):147-152
There have been several case reports of neurological manifestations in pediatrics as severe acute respiratory syndrome coronavirus-2 infection in children is being increased. We report a case of a 4-year-old boy who presented febrile seizure during follow-up in a negative pressure isolation room after confirmed coronavirus disease 2019, which has not yet been reported in Korea. He has no symptoms other than fever. The seizure was controlled after one dose of intravenous lorazepam, and there was no respiratory support during the hospitalization. He was discharged 12 days later without neurological sequelae.
3.Febrile Seizure Associated With COVID-19 in a Child: Case Report and Literature Review
Yu Ri JO ; Nayoung JUNG ; Min Kyoung KIM ; Young Se KWON ; Dong Hyun KIM
Pediatric Infection & Vaccine 2024;31(1):147-152
There have been several case reports of neurological manifestations in pediatrics as severe acute respiratory syndrome coronavirus-2 infection in children is being increased. We report a case of a 4-year-old boy who presented febrile seizure during follow-up in a negative pressure isolation room after confirmed coronavirus disease 2019, which has not yet been reported in Korea. He has no symptoms other than fever. The seizure was controlled after one dose of intravenous lorazepam, and there was no respiratory support during the hospitalization. He was discharged 12 days later without neurological sequelae.
4.Febrile Seizure Associated With COVID-19 in a Child: Case Report and Literature Review
Yu Ri JO ; Nayoung JUNG ; Min Kyoung KIM ; Young Se KWON ; Dong Hyun KIM
Pediatric Infection & Vaccine 2024;31(1):147-152
There have been several case reports of neurological manifestations in pediatrics as severe acute respiratory syndrome coronavirus-2 infection in children is being increased. We report a case of a 4-year-old boy who presented febrile seizure during follow-up in a negative pressure isolation room after confirmed coronavirus disease 2019, which has not yet been reported in Korea. He has no symptoms other than fever. The seizure was controlled after one dose of intravenous lorazepam, and there was no respiratory support during the hospitalization. He was discharged 12 days later without neurological sequelae.
5.Interictal Gastric Motility in Patients with Migraine.
Yu Ri JEONG ; Minho HWANG ; Kyusik KANG ; Ohyun KWON ; Jong Moo PARK ; JungJu LEE ; Yunju JO ; Byung Kun KIM
Journal of the Korean Neurological Association 2011;29(4):291-294
BACKGROUND: Nausea and vomiting are predominant accompanying symptoms of migraine attacks. Although the underlying mechanism is not yet clear, gastric stasis is assumed to be the main factor. However, few studies have used direct methods to establish delayed gastric emptying of migraine patients. We compared interictal gastric motility between migraine patients and normal controls with the aid of gastric scintigraphy. METHODS: The study population comprised patients who had been diagnosed with episodic migraine, according to the International Classification of Headache Disorders, edition II. The entire study population was completely free of gastrointestinal symptoms during the headache-free period. Gastric scintigraphy was performed to determine the time to half emptying (T 1/2) and the percentage of radioactive material remaining in the stomach (%RMR) at 30, 60, 90, and 120 min. RESULTS: Twenty-six migraine patients and 12 normal controls were recruited. The mean T 1/2 did not differ between the two groups (101.8 vs 95.2 min; p=0.432). The %RMR values in the stomach at 30, 60, 90, and 120 min also did not differ significantly between the two groups [87.5% vs 88% (p=0.900), 70.8% vs 71.2% (p=0.950), 54.2% vs 53.3% (p=0.753), and 39.0% vs 37.3% (p=0.583), respectively]. CONCLUSIONS: There is no gastric stasis in patients with episodic migraine during headache-free periods. Our results suggest that the main mechanism underlying the nausea and vomiting in migraine patients is not a gastric stasis in interictal periods, but rather a central process, as a result of changes occurring in the brainstem during acute migraine attacks.
Brain Stem
;
Gastric Emptying
;
Gastroparesis
;
Headache Disorders
;
Humans
;
Migraine Disorders
;
Nausea
;
Stomach
;
Vomiting
6.Safety of Fertility-Sparing Surgery in Primary Mucinous Carcinoma of the Ovary.
Jung Yun LEE ; Yu Ri JO ; Tae Hun KIM ; Hee Seung KIM ; Min A KIM ; Jae Weon KIM ; Noh Hyun PARK ; Yong Sang SONG
Cancer Research and Treatment 2015;47(2):290-297
PURPOSE: The aim of this study is to evaluate the safety of fertility-sparing surgery as the treatment for patients with primary mucinous epithelial ovarian cancer. MATERIALS AND METHODS: A retrospective study of patients with mucinous ovarian cancer between 1991 and 2010 was performed. The demographics and survival outcomes were compared between patients who underwent fertility-sparing surgery and those who underwent radical surgery. RESULTS: A total of 110 patients underwent primary surgery. At the time of surgery, tumors appeared to be grossly confined to the ovaries in 90 patients, and evidence of metastasis was definite in 20 patients. Of the 90 patients with tumors that appeared to be grossly confined to the ovaries at surgical exploration, 35 (38.9%) underwent fertility-sparing surgery. The Kaplan- Meier curve and the log rank test showed no difference in either recurrence-free survival (p=0.792) or disease-specific survival (p=0.706) between the two groups. Furthermore, there was no significant difference in recurrence-free survival (p=0.126) or disease-specific survival (p=0.377) between the two groups, even when the analysis was limited to women below the age of 40. In a multivariate Cox model, fertility-sparing surgery had no effect on either recurrence-free survival (recurrence hazard ratio [HR], 1.20; 95% confidence interval [CI], 0.25 to 5.71) or disease-specific survival (death HR, 0.88; 95% CI, 0.17 to 4.60). CONCLUSION: Fertility-sparing surgery in primary mucinous cancer grossly confined to the ovaries may be a safe option and one not associated with an increase in recurrence or mortality.
Adenocarcinoma, Mucinous*
;
Demography
;
Female
;
Humans
;
Mortality
;
Mucins
;
Neoplasm Metastasis
;
Ovarian Neoplasms
;
Ovary*
;
Recurrence
;
Retrospective Studies
7.A Case of Diffuse Large B-cell Lymphoma with Liver Involvement in a 67-Year-Old Woman Given Methotrexate for Rheumatoid Arthritis.
Jae Young CHEON ; Hee Seung CHOI ; Se Hee JO ; Seohui LEE ; Mi Ok CHO ; Min Young LEE ; Yu Ri KIM
Korean Journal of Medicine 2015;88(6):715-718
Prolonged inflammation or immunosuppression may cause lymphoproliferative disorders (LPD). Rheumatoid arthritis (RA) itself causes LPD. The immunosuppressive drug methotrexate (MTX) is used widely to treat RA, and is also related to the development of lymphoma. Although the detailed pathogenesis and association are still controversial, care is needed when managing patients with RA treated with MTX. Many reports indicate that discontinuing MTX can induce the regression of LPD. Here, we describe a case of diffuse large B-cell lymphoma that presented with liver involvement in a 67-year-old woman who had used MTX for RA for 15 years.
Aged*
;
Arthritis, Rheumatoid*
;
Female
;
Humans
;
Immunosuppression
;
Inflammation
;
Liver*
;
Lymphoma
;
Lymphoma, B-Cell*
;
Lymphoproliferative Disorders
;
Methotrexate*
8.Development of Warfarin Talk: A Messenger Chatbot for Patients Taking Warfarin
Han Sol LEE ; Yu Ri KIM ; Eun Jeong SHIN ; Hong Won JANG ; Yun Hee JO ; Yoon Sook CHO ; Jung Hoon KIM ; Ju-Yeun LEE
Korean Journal of Clinical Pharmacy 2020;30(4):243-249
Background:
Despite the increased use of direct-acting oral anticoagulants, warfarin is still recommended as first-line therapy in patients with mechanical valves or moderate to severe mitral stenosis. Anticoagulation management services (AMSs) are warranted for patients receiving warfarin therapy due to the complexity of warfarin dosing and large interpatient variability. To overcome limited health care resources, we developed a messenger app-based chatbot that provides information to patients taking warfarin.
Methods:
We developed “WafarinTalk” as an add-on to the open-source messenger app KakaoTalk. We developed the prototype chatbot after building a database containing seven categories: 1) dosage and indications, 2) drug-drug interactions, 3) drug-food interactions, 4) drug-diet supplement interactions, 5) monitoring, 6) adverse events, and 7) precautions. We then surveyed 30 pharmacists and 10 patients on chatbot reliability and on participant satisfaction.
Results:
We found that 80% of the pharmacists agreed on the consistency of chatbot responses and 44% agreed on the appropriateness of chatbot. Furthermore, 47% of pharmacists said that they were willing to recommend the chatbot to patients. Of the seven categories, information on drug-food interaction was the most useful; 90% of patients said they were satisfied with the chatbot and 100% of patients said they were willing to use it when they were unable to see a pharmacist. We updated the prototype chatbot with feedback from the survey.
Conclusion
This study showed that warfarin-related information could be provided to patients through a messenger applicationbased chatbot.
9.Development of Warfarin Talk: A Messenger Chatbot for Patients Taking Warfarin
Han Sol LEE ; Yu Ri KIM ; Eun Jeong SHIN ; Hong Won JANG ; Yun Hee JO ; Yoon Sook CHO ; Jung Hoon KIM ; Ju-Yeun LEE
Korean Journal of Clinical Pharmacy 2020;30(4):243-249
Background:
Despite the increased use of direct-acting oral anticoagulants, warfarin is still recommended as first-line therapy in patients with mechanical valves or moderate to severe mitral stenosis. Anticoagulation management services (AMSs) are warranted for patients receiving warfarin therapy due to the complexity of warfarin dosing and large interpatient variability. To overcome limited health care resources, we developed a messenger app-based chatbot that provides information to patients taking warfarin.
Methods:
We developed “WafarinTalk” as an add-on to the open-source messenger app KakaoTalk. We developed the prototype chatbot after building a database containing seven categories: 1) dosage and indications, 2) drug-drug interactions, 3) drug-food interactions, 4) drug-diet supplement interactions, 5) monitoring, 6) adverse events, and 7) precautions. We then surveyed 30 pharmacists and 10 patients on chatbot reliability and on participant satisfaction.
Results:
We found that 80% of the pharmacists agreed on the consistency of chatbot responses and 44% agreed on the appropriateness of chatbot. Furthermore, 47% of pharmacists said that they were willing to recommend the chatbot to patients. Of the seven categories, information on drug-food interaction was the most useful; 90% of patients said they were satisfied with the chatbot and 100% of patients said they were willing to use it when they were unable to see a pharmacist. We updated the prototype chatbot with feedback from the survey.
Conclusion
This study showed that warfarin-related information could be provided to patients through a messenger applicationbased chatbot.